Transforming tumors into ‘high-risk bombs’ triggers a neoantigen storm and amplifies immune responses
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.02.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Yunlong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230031, China. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Anhui Provincial Quality Engineering Project, Anhui Province Excellent Young Talents Fund Program of Higher Education Institutions, Anhui Province Department of Education.
Abstract (Originalsprache)
Although various immunotherapies have improved the treatment of several challenging malignancies in clinical applications, current research suggests that neoantigens remain fundamental to the initiation of immunotherapy, implying a dependence on high mutation loads in tumors and stable target antigens. To overcome these limitations, we propose a novel immunotherapy paradigm that interferes with splicing to induce the expression of neoantigens and neoepitopes while simultaneously blocking autophagy to prevent their degradation through endogenous pathways. This approach ensures the stable expression and accumulation of neoantigens and neoepitopes in tumor cells. To fully unleash the potential of neoantigens, we further induce tumors to undergo immunogenic cell death (ICD), triggering a "neoantigen storm" at the tumor site to recruit and activate more dendritic cells (DCs). Through a DC-dependent mechanism, communication between the tumor and the tumor-draining lymph node (TDLN) is enhanced, summoning more neoantigen-specific cytotoxic T lymphocytes to lyse tumor cells and establish immune circulation. In summary, this work presents a novel antigen-based immune sensitization strategy that stabilizes target antigens while exploring the potential of non-targeted antigens. By bypassing the cumbersome neoantigen identification process, this strategy holds promise for rapid clinical application in combination with other immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230031, China.
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230031, China; Anhui Provincial Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei 230021, China. Electronic address: wshen@aht…
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230031, China; Anhui Province Key Laboratory of Chinese Medicinal Formula, Hefei 230031, China; Engineering Technology Research Center of Modernized Pharma…
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230031, China; Anhui Provincial Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei 230021, China; Engineering Technology Resear…
Förderung
- Anhui Provincial Quality Engineering Project
- Anhui Province Excellent Young Talents Fund Program of Higher Education Institutions
- Anhui Province Department of Education
- National Natural Science Foundation of China
- Chengdu University of Traditional Chinese Medicine
- Anhui University of Chinese Medicine
Zitieren
APA
Li, Y., Sun, Q., Yang, Z., Luo, M., Yang, W., Song, Z., Liu, K., Li, H., Gao, W., Wu, Q., Shen, W., Yang, Y., & Yin, D. (2025). Transforming tumors into ‘high-risk bombs’ triggers a neoantigen storm and amplifies immune responses. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.040
Vancouver
Li Y, Sun Q, Yang Z, Luo M, Yang W, Song Z, et al. Transforming tumors into ‘high-risk bombs’ triggers a neoantigen storm and amplifies immune responses. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.040
BibTeX
@article{Li2025,
author = {Li, Yunlong and Sun, Quanwei and Yang, Zexin and Luo, Min and Yang, Wenshuo and Song, Zhengwei and Liu, Kang and Li, Huihui and Gao, Wenheng and Wu, Qinghua and Shen, Wei and Yang, Ye and Yin, Dengke},
title = {Transforming tumors into ‘high-risk bombs’ triggers a neoantigen storm and amplifies immune responses},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.02.040}
}
EUVIMED